|
PDCD2 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 9.154600E-01 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
6.069800E-01 |
| Normal-vs-Stage2 |
7.852200E-01 |
| Normal-vs-Stage3 |
9.177400E-01 |
| Normal-vs-Stage4 |
7.969900E-02 |
| Stage1-vs-Stage2 |
5.679400E-01 |
| Stage1-vs-Stage3 |
8.377200E-01 |
| Stage1-vs-Stage4 |
6.493900E-02 |
| Stage2-vs-Stage3 |
7.700800E-01 |
| Stage2-vs-Stage4 |
1.072190E-01 |
| Stage3-vs-Stage4 |
8.205900E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
6.360600E-01 |
| Normal-vs-AfricanAmerican |
2.266600E-01 |
| Normal-vs-Asian |
6.632000E-01 |
| Caucasian-vs-AfricanAmerican |
1.093180E-01 |
| Caucasian-vs-Asian |
5.577600E-01 |
| AfricanAmerican-vs-Asian |
9.639200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
6.638000E-01 |
| Normal-vs-Female |
5.002000E-01 |
| Male-vs-Female |
2.665000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
8.287200E-01 |
| Normal-vs-Extreme_Weight |
8.379500E-02 |
| Normal-vs-Obese |
4.587400E-01 |
| Normal-vs-Extreme_Obese |
8.868200E-01 |
| Normal_Weight-vs-Extreme_Weight |
1.072190E-01 |
| Normal_Weight-vs-Obese |
6.574600E-01 |
| Normal_Weight-vs-Extreme_Obese |
8.094400E-01 |
| Extreme_Weight-vs-Obese |
4.417900E-02 |
| Extreme_Weight-vs-Extreme_Obese |
4.946000E-01 |
| Obese-vs-Extreme_Obese |
6.567000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
6.872000E-01 |
| Normal-vs-Age(41-60Yrs) |
3.038000E-01 |
| Normal-vs-Age(61-80Yrs) |
4.462600E-01 |
| Normal-vs-Age(81-100Yrs) |
1.439630E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.221000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.146400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.179600E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.807900E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.777500E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.734220E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
8.825200E-01 |
| Normal-VS-Type2 PRCC |
7.577200E-01 |
| Normal-VS-KIRP CIMP |
3.373800E-01 |
| Normal-VS-Unclassified PRCC |
1.473590E-01 |
| Type1 PRCC-VS-Type2 PRCC |
6.605200E-01 |
| Type1 PRCC-VS-KIRP CIMP |
3.505800E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
7.786400E-02 |
| Type2 PRCC-VS-KIRP CIMP |
2.486400E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
3.560000E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
6.401700E-02 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.040570E-01 |
| Normal-vs-N1 |
2.098200E-01 |
| Normal-vs-N2 |
7.379400E-03 |
| N0-vs-N1 |
4.438400E-02 |
| N0-vs-N2 |
2.602400E-01 |
| N1-vs-N2 |
9.849800E-02 |
|
|
